These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29465067)

  • 21. Transforming growth factor-beta pathway disruption and infiltration of colorectal cancers by intraepithelial lymphocytes.
    Baker K; Chong G; Foulkes WD; Jass JR
    Histopathology; 2006 Oct; 49(4):371-80. PubMed ID: 16978200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multispectral imaging reveals hyper active TGF-β signaling in colorectal cancer.
    Yang L; Liu Z; Tan J; Dong H; Zhang X
    Cancer Biol Ther; 2018 Feb; 19(2):105-112. PubMed ID: 29219668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FBXO32, a new TGF-β/Smad signaling pathway target gene, is epigenetically inactivated in gastric cardia adenocarcinoma.
    Guo W; Zhang M; Guo Y; Shen S; Guo X; Dong Z
    Neoplasma; 2015; 62(4):646-57. PubMed ID: 25997968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
    Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
    BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.
    Voorneveld PW; Kodach LL; Jacobs RJ; van Noesel CJ; Peppelenbosch MP; Korkmaz KS; Molendijk I; Dekker E; Morreau H; van Pelt GW; Tollenaar RA; Mesker W; Hawinkels LJ; Paauwe M; Verspaget HW; Geraets DT; Hommes DW; Offerhaus GJ; van den Brink GR; Ten Dijke P; Hardwick JC
    Br J Cancer; 2015 Jan; 112(1):122-30. PubMed ID: 25393365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
    Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
    Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer.
    Liu Y; Sheng J; Dai D; Liu T; Qi F
    Pathol Res Pract; 2015 Apr; 211(4):286-92. PubMed ID: 25680269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Smad4 and TGF-beta2 in colorectal carcinoma.
    Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S
    Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity.
    Quan J; Ma C
    Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells.
    Lei KF; Liu BY; Wang YF; Chen XH; Yu BQ; Guo Y; Zhu ZG
    Oncol Rep; 2011 Nov; 26(5):1115-20. PubMed ID: 21725612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.
    Habel N; El-Hachem N; Soysouvanh F; Hadhiri-Bzioueche H; Giuliano S; Nguyen S; Horák P; Gay AS; Debayle D; Nottet N; Béranger G; Paillerets BB; Bertolotto C; Ballotti R
    Cell Death Differ; 2021 Jun; 28(6):1837-1848. PubMed ID: 33462405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of atrogin-1/F-box protein-32 (FBXO32) and F-box protein-25 (FBXO25) in rainbow trout (Oncorhynchus mykiss): Expression across tissues in response to feed deprivation.
    Cleveland BM; Evenhuis JP
    Comp Biochem Physiol B Biochem Mol Biol; 2010 Nov; 157(3):248-57. PubMed ID: 20601059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmed Cell Death Ligand 1 Expression Is an Independent Prognostic Factor in Colorectal Cancer.
    Enkhbat T; Nishi M; Takasu C; Yoshikawa K; Jun H; Tokunaga T; Kashihara H; Ishikawa D; Shimada M
    Anticancer Res; 2018 Jun; 38(6):3367-3373. PubMed ID: 29848685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer.
    Oyanagi H; Shimada Y; Nagahashi M; Ichikawa H; Tajima Y; Abe K; Nakano M; Kameyama H; Takii Y; Kawasaki T; Homma KI; Ling Y; Okuda S; Takabe K; Wakai T
    Histopathology; 2019 May; 74(6):873-882. PubMed ID: 30636020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibin, beta A regulates the transforming growth factor-beta pathway to promote malignant biological behaviour in colorectal cancer.
    He Z; Liang J; Wang B
    Cell Biochem Funct; 2021 Mar; 39(2):258-266. PubMed ID: 32662905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
    Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
    J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.